Hypersomnia Fdn (@hypersomnianews) 's Twitter Profile
Hypersomnia Fdn

@hypersomnianews

We engage, inform & champion our global community to improve the lives of people w/ #hypersomnia & related #sleep disorders. #Beyondsleepy #Narcolepsy #KLS

ID: 2557418599

linkhttp://hypersomniafoundation.org/donate calendar_today09-06-2014 19:31:19

2,2K Tweet

1,1K Followers

754 Following

Hypersomnia Fdn (@hypersomnianews) 's Twitter Profile Photo
Hypersomnia Fdn
@hypersomnianews

3 months ago

On August 22nd, Alkermes announced the initiation of the Vibrance-2 study, a phase 2 clinical trial evaluating the safety and efficacy of ALKS 2680 compared to placebo in adults with narcolepsy type 2 (NT2). Read the full article at: tinyurl.com/yb5dyauv

On August 22nd, Alkermes announced the initiation of the Vibrance-2 study, a phase 2 clinical trial evaluating the safety and efficacy of ALKS 2680 compared to placebo in adults with narcolepsy type 2 (NT2). Read the full article at: tinyurl.com/yb5dyauv